Investor
The startup previously raised $14 million in 2020.
The company will use the funds to continue its growth in the U.S.
The latest cohort includes 23 companies focused on technology for retaining, deploying and training healthcare workers.
In a letter, the senator urged the agency to scrutinize the acquisition and others like it, arguing the deal could increase costs and lower quality of care.
Christopher Lis, managing director of global healthcare intelligence at J.D. Power, discusses the recent primary care deals by Amazon and CVS Health.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
It also received backing from the founding members of Grab and Zalora.
The acquisition includes Mindstrong's technology assets and some of its employees.
The program will be available through Amwell in the second half of 2023.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.